MedPath

Dengue - Sample Collection Study Pakistan

Not yet recruiting
Conditions
Dengue
Registration Number
NCT07203183
Lead Sponsor
Abbott Rapid Dx
Brief Summary

The objective of this study is to collect well-characterized serum and plasma specimens from confirmed dengue positive and dengue negative subjects to support dengue diagnostic products development.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Age ≥12-years-old
  • Individuals suspected or confirmed for active dengue, with dengue-consistent symptoms onset up to and including 10 days before enrolment in this trial.
Exclusion Criteria
  • Subject has been vaccinated for dengue.
  • Subject participates in an investigative drug, vaccine or medical device clinical study
  • Participant is deemed unfit for the study by the Investigator
  • Participant is unwilling or unable to provide informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sample collection only, no specific outcome needed5 months
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.